Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Psychoneuroendocrinology. 2020 May 5;119:104694. doi: 10.1016/j.psyneuen.2020.104694

Figure 2.

Figure 2.

Mean (±SEM) E2 (A) and progesterone (B) levels following administration of mecamylamine (3.0 mg/kg) in nicotine-treated intact females that were tested in the proestrus (n=12), estrus (n=12), metestrus (n=7), or diestrus (n=7) phase of the estrous cycle. Daggers (†). denote a significant difference from all other groups (p≤0.05).